INS and diabetes mellitus: Inhalable nanoparticles composed of glycol chitosan [169], chitosan-coated PLGA [170], or polybutylcyanoacrylate [171] also have sustained-release characteristics for calcitonin [169,170], insulin [171], and exendin-4 [167], and prolonged therapeutic effects in osteoporosis and diabetes [172].